Sign up to save your podcasts
Or
Share Interview with Drs. Charu Aggarwal & Balazs Halmos: Adjuvant & Neoadjuvant Therapy for Lung Cancer
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Interview with Drs. Charu Aggarwal & Balazs Halmos: Adjuvant & Neoadjuvant Therapy for Lung Cancer
Caris Precision Oncology Alliance™ Chairman, Dr. Chadi Nabhan, sits down with Dr. Charu Aggarwal, the Leslye M. Heisler Associate Professor for Lung Cancer Excellence at UPENN, and Dr. Balazs Halmos, Director, Thoracic Oncology at Montefiore. Together they discuss adjuvant and neoadjuvant therapy for resected non-small cell lung cancer (NSCLC). Topics discussed will include current treatment options, how treatment decision are made, and when treatment should be given.
For more information, please visit: www.CarisLifeSciences.com/POA-Intro/
View all episodes
By Dr. Chadi Nabhan - Chairman, POACaris Precision Oncology Alliance™ Chairman, Dr. Chadi Nabhan, sits down with Dr. Charu Aggarwal, the Leslye M. Heisler Associate Professor for Lung Cancer Excellence at UPENN, and Dr. Balazs Halmos, Director, Thoracic Oncology at Montefiore. Together they discuss adjuvant and neoadjuvant therapy for resected non-small cell lung cancer (NSCLC). Topics discussed will include current treatment options, how treatment decision are made, and when treatment should be given.
For more information, please visit: www.CarisLifeSciences.com/POA-Intro/